The vasoactive intestinal peptide analogue RO25-1553 inhibits the production of TNF and IL-12 by LPS-activated monocytes

Immunol Lett. 1998 Jan;60(1):57-60. doi: 10.1016/s0165-2478(97)00129-6.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Interleukin-10 / biosynthesis
  • Interleukin-12 / antagonists & inhibitors*
  • Interleukin-12 / biosynthesis
  • Lipopolysaccharides / pharmacology*
  • Mitogens / pharmacology*
  • Monocytes / drug effects*
  • Monocytes / metabolism
  • Peptides, Cyclic / pharmacology*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Tumor Necrosis Factor-alpha / biosynthesis
  • Vasoactive Intestinal Peptide / analogs & derivatives*
  • Vasoactive Intestinal Peptide / pharmacology

Substances

  • Lipopolysaccharides
  • Mitogens
  • Peptides, Cyclic
  • Ro 25-1553
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Interleukin-12
  • Vasoactive Intestinal Peptide